MTVA: MetaVia, Inc. EV/EBITDA Multiple
MetaVia Inc (MTVA) is a non-cyclical biotech firm whose success depends on scientific research milestones rather than market cycles. The brand's high authority among neurologists ensures investor loyalty. The asset's market dynamics on GURU.Markets based on the EV/EBITDA metric stand at 0.00. The business relies on unique patents that, following successful tests, will allow the company to exercise pricing power over its drugs.
Metric breakdowns and analytics for metaviatx.com (MTVA)
- stock price and consensus target price:
- market capitalization information:
- issuer book value statistics:
- issuer credit burden and liquidity indicators:
- net income and valuation multiples indicators:
MTVA - Net Income|Expected Profit MetaVia Inc|MTVA - Price to Earnings Ratio|Projected Price to Earnings MetaVia|MTVA - Company Value to Earnings Growth Ratio|Enterprise Value to EBITDA Ratio MetaVia|MTVA - Profit before payment of interest, taxes and amortization|Net earnings per share (EPS TTM) MetaVia|MTVA - Net earnings per share (EPS TTM)|Year-over-year earnings per share growth for the last twelve months metaviatx.com|MTVA - Earnings per share growth this year|Earnings growth forecast for next year MetaVia Inc
Summary company analysis:MetaVia, Inc. MTVA
An investor is assessing the resilience of MetaVia Inc (MTVA) through the ratio of enterprise value to operating profit, which is critical for capital-intensive biotechnological developments in neurosurgery. By analyzing the trend level of the company's EV/EBITDA, one can determine the fairness of the asset's market price relative to its debt load and the efficiency of developing new treatments for Alzheimer's disease.
Analysis of competing companies
Biogen Corp - Enterprise Value to EBITDA Ratio|Enterprise Value to Operating Income Before Depreciation Ratio NBIX (Neurocrine Corp)|Regencell Bioscience - EV/EBITDA Multiple|AXSM - EV/EBITDA Multiple|ACAD (ACADIA Pharmaceuticals Inc.) - Enterprise Value to EBITDA Ratio|XENE (Xenon Pharmaceuticals Inc.) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|VKTX (Viking Pharma) - EV/EBITDA Multiple|Supernus Corp (SUPN) - Total Company Value to Operating Income Before Depreciation Ratio|EV/EBITDA Multiple CPRX|EV/EBITDA Multiple denalitherapeutics.com (DNLI)|Harmony Biosciences Holdings, Inc. - Enterprise Value to EBITDA Ratio|Business Value to Operating Income Before Depreciation BHVN|Amylyx - EV/EBITDA Multiple|Total Company Value to Operating Income Before Depreciation Ratio Trevi Corp TRVI|Praxis Precision Medicines (PRAX) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Enterprise Value to Operating Income Before Depreciation AVXL|CBLL (CeriBell) - EV/EBITDA Multiple|Enterprise Value to EBITDA Ratio Prothena Corporation PLC (PRTA)|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Alector, Inc. (ALEC)|Enterprise Value to EBITDA Ratio Annexon Biosciences Inc. ANNX|Omeros - Enterprise Value to EBITDA Ratio|Enterprise Value to Operating Income Before Depreciation Ratio NGNE (neurogene.com)|ACIU: Enterprise Value to EBITDA Ratio|VYGR: Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|NMRA: EV/EBITDA Multiple|Scilex Holding Company, Inc. (SCLX) - EV/EBITDA Multiple|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Tevogen Bio Holdings|Enterprise Value to Operating Income Before Depreciation ACOG (Alpha Cognition Corp)|EV/EBITDA Multiple CGTX|IKT - Company Value to EBITDA|Cassava - Enterprise Value to EBITDA Ratio|EV/EBITDA Multiple Assertio Holdings ASRT|COYA - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Business Value to Operating Income Before Depreciation VTGN (Vistagen Therapeutics)|ovidrx.com (OVID) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Company Value to EBITDA Acumen Pharmaceuticals Inc. (ABOS)|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization CervoMed Inc|Enterprise Value to EBITDA Ratio Alterity Therapeutics Ltd (ATHE)|EV/EBITDA Multiple CLNN|PEPG - Company Value to EBITDA|Jupiter Neurosciences - Enterprise Value to EBITDA Ratio|Enterprise Value to Operating Income Before Depreciation Ratio RLMD (Relmada Therapeutics Inc)|Annovis Bio Corp - EV/EBITDA Multiple|GRCE - EV/EBITDA Multiple|AIFF (Firefly Neuroscience, Inc) - Enterprise Value to EBITDA Ratio|KLTO (Klotho Neurosciences) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|NRSN (NeuroSense Therapeutics Ltd) - EV/EBITDA Multiple|Reviva Pharmaceuticals Holdings Inc. (RVPH) - Total Company Value to Operating Income Before Depreciation Ratio|EV/EBITDA Multiple NRXS|EV/EBITDA Multiple heliusmedical.com (HSDT)|Passage Bio - Enterprise Value to EBITDA Ratio|Business Value to Operating Income Before Depreciation NEUP|Minerva Neurosciences, Inc. - EV/EBITDA Multiple|Total Company Value to Operating Income Before Depreciation Ratio Athira Pharma Inc ATHA|Addex Therapeutics, Ltd. (ADXN) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Enterprise Value to Operating Income Before Depreciation ALZN|CYCN (Cyclerion Therapeutics Inc.) - EV/EBITDA Multiple|Enterprise Value to EBITDA Ratio Protagenic (PTIX)|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Pasithea Therapeutics (KTTA)|Enterprise Value to EBITDA Ratio cortigent.com CRGT|Avenue Therapeutics, Inc - Enterprise Value to EBITDA Ratio|Enterprise Value to Operating Income Before Depreciation Ratio BCLI (BrainStorm Cell Therapeutics Inc.)|CARA: Enterprise Value to EBITDA Ratio|CHRO: Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|ELYM: EV/EBITDA Multiple|Intra-Cellular Therapies, Inc. (ITCI) - EV/EBITDA Multiple|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Longboard Pharma|Enterprise Value to Operating Income Before Depreciation MRNS (Marinus Pharma)|EV/EBITDA Multiple NKGN|NRBO - Company Value to EBITDA|Sage Therapeutics - Enterprise Value to EBITDA Ratio|EV/EBITDA Multiple Synaptogenix Inc. SNPX|TRVN - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Business Value to Operating Income Before Depreciation VIGL (Vigil Neuroscience)|Anew Medical, Inc. (WENA) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Company Value to EBITDA cerevel.com (CERE)
